Predix Pharmaceuticals Holdings Overview
- Status
-
Acquired/Merged
- Employees
-
26
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$90M
Predix Pharmaceuticals Holdings General Information
Description
Operator of a drug development company. The company focuses on the discovery and development of small-molecule drugs that target G-protein coupled receptors (GPCRs) and ion channels, used in the treatment of treating anxiety, Alzheimer's disease, pulmonary arterial hypertension and other diseases.
Contact Information
Website
www.predixpharm.comCorporate Office
- 4 Maguire Road
- Lexington, MA 02421
- United States
Corporate Office
- 4 Maguire Road
- Lexington, MA 02421
- United States
Predix Pharmaceuticals Holdings Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 16-Aug-2006 | $90M | Completed | Clinical Trials - Phase 2 | ||
| 8. IPO | 26-Oct-2005 | Cancelled | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series C) | 25-Jan-2005 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 09-Aug-2004 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 22-Aug-2003 | Completed | Product Development | |||
| 4. Later Stage VC (Series E) | 01-Aug-2001 | Completed | Product Development | |||
| 3. Later Stage VC | 02-Nov-2000 | Completed | Product Development | |||
| 2. Later Stage VC (Series C) | 13-May-1999 | $11.8M | $21.8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series B) | 06-Nov-1997 | $10M | $10M | Completed | Generating Revenue |
Predix Pharmaceuticals Holdings Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series AB |
Predix Pharmaceuticals Holdings Patents
Predix Pharmaceuticals Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20070173487-A1 | 1-(4-(5-phenylbenzofuran-2-yl)benzyl)azetidine-3-carboxylic acids; anticarcinogenic, antiinflammatory, antiarthritic, antidiabetic agents; transplant rejection, autoimmune diseases, lupus, multiple sclerosis, psoriasis, inflammatory bowel disease, chron's disease | Active | 22-Dec-2005 | ||
| US-20080064677-A9 | 1-(4-(5-phenylbenzofuran-2-yl)benzyl)azetidine-3-carboxylic acids; anticarcinogenic, antiinflammatory, antiarthritic, antidiabetic agents; transplant rejection, autoimmune diseases, lupus, multiple sclerosis, psoriasis, inflammatory bowel disease, chron's disease | Active | 22-Dec-2005 | ||
| WO-2007061458-A2 | S1p receptor modulating compounds and use thereof | Inactive | 23-Nov-2005 | ||
| WO-2006081332-A1 | Substituted arylamine compounds and their use as 5-ht6 modulators | Inactive | 25-Jan-2005 | ||
| WO-2006041985-A2 | Thienopyridinone compounds and methods of treatment | Inactive | 07-Oct-2004 | C07D495/04 |
Predix Pharmaceuticals Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Predix Pharmaceuticals Holdings Former Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| Auckland UniServices | Corporate Venture Capital | Minority | ||
| Boston Millennia Partners | Venture Capital | Minority | ||
| DrKB Life Science Partners | Other | Minority | ||
| Forward Ventures | Venture Capital | Minority |
Predix Pharmaceuticals Holdings Acquisitions (1)
Predix Pharmaceuticals Holdings’s most recent deal was a Merger/Acquisition with Physiome Sciences. The deal was made on 13-Aug-2003.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Physiome Sciences | 13-Aug-2003 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Predix Pharmaceuticals Holdings FAQs
-
Where is Predix Pharmaceuticals Holdings headquartered?
Predix Pharmaceuticals Holdings is headquartered in Lexington, MA.
-
What is the size of Predix Pharmaceuticals Holdings?
Predix Pharmaceuticals Holdings has 26 total employees.
-
What industry is Predix Pharmaceuticals Holdings in?
Predix Pharmaceuticals Holdings’s primary industry is Drug Discovery.
-
Is Predix Pharmaceuticals Holdings a private or public company?
Predix Pharmaceuticals Holdings is a Private company.
-
What is the current valuation of Predix Pharmaceuticals Holdings?
The current valuation of Predix Pharmaceuticals Holdings is .
-
What is Predix Pharmaceuticals Holdings’s current revenue?
The current revenue for Predix Pharmaceuticals Holdings is .
-
How much funding has Predix Pharmaceuticals Holdings raised over time?
Predix Pharmaceuticals Holdings has raised $73.7M.
-
Who are Predix Pharmaceuticals Holdings’s investors?
Astellas Venture Management, Auckland UniServices, Boston Millennia Partners, DrKB Life Science Partners, and Forward Ventures are 5 of 19 investors who have invested in Predix Pharmaceuticals Holdings.
-
When was Predix Pharmaceuticals Holdings acquired?
Predix Pharmaceuticals Holdings was acquired on 16-Aug-2006.
-
Who acquired Predix Pharmaceuticals Holdings?
Predix Pharmaceuticals Holdings was acquired by EPIX Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
